speb/financial-data huggingface dataset:
Financial scorecard for OCC.AX (Healthcare — Biotechnology, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.4930555555555555
Market cap: 193355696 (USD: 126376271.89542483)
P/B ratio: 21.870548759770337
Debt to equity: 0.0124
Current ratio: 9.17
Return on net tangible assets (%): -61.345457999532336
Buffett classification: The Gruesome
Analyst consensus upside (%): 60.84615384615385
Rule of 40 score: -80.48233758058198
Altman Z-score: 2.4417197967007365 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0.45615413367496555
Debt paydown yield (%): 0.06547097531587587
Total shareholder yield (%): 0.5216251089908415 (Low Return)
Momentum (%): 1m -3.387762762762773, 3m -20.657726692209458, 6m -25.787514318442156, 12m -46.820436507936506, composite -30.46696867842738 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 3, short score 8, recommendation: Short
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
ROE (%): -89.27275375451265
Net margin (%): -113.4551969550826
Asset turnover: 0.242068704276865
Equity multiplier (leverage): 3.250542822932102
ROE archetype: Low Return
Treasury beta 1y: 0.005239750692549396 (R-squared: 0.0014192508494369706)
Insider 90-day net shares: 48615 (net value USD: 31943.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 62.545126353790614, ROIC , revenue growth 1y , 6m momentum 48.285198555956676
Sector percentiles: P/E , 6m momentum 54.79942693409742
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.05
Base cash flow: -5411456.862745099
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for OCN.AX (Basic Materials — Other Industrial Metals & Mining, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.2777777777777778
Market cap: 94159000 (USD: 61541830.06535947)
P/E ratio: 0.6535947712418301
Current ratio: 14.75
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -22.542735042735053, 3m -11.616161616161627, 6m 35.1851851851852, 12m 499.2063492063492, composite 232.38836089410802 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 0, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: -0.0015358334120710662 (R-squared: 3.4927298922961145e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 3.1640299750208163, P/B , ROIC , revenue growth 1y , 6m momentum 6.328059950041633
Sector percentiles: P/E 16.213214880621877, 6m momentum 6.413103831204886
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.11180000000000001
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for OCO.V (Basic Materials — Other Industrial Metals & Mining, Canada)
Report date: 2026-02-28 (quarterly)
Stock price: 0.2553191489361702
Market cap: 117343496 (USD: 85652186.86131386)
P/B ratio: 1.8496799357933271
Debt to equity: 0.0018
Current ratio: 5.71
Return on net tangible assets (%): -3.472200791298431
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: 19.35381912899142 (Safe Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.005909129016770204
Total shareholder yield (%): 0.005909129016770204 (Low Return)
Momentum (%): 1m -2.0126509488211637, 3m -12.553191489361701, 6m -30.91364205256572, 12m 15.744680851063839, composite -8.44825593807596 (Moderate Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 8, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.022206128742032635
FCF conversion rate: 0.40325636283651206
Beneish M-score: -2.9541796952121167 (Likely Safe)
ROE (%): -3.837953571146793
Asset turnover: 0
Equity multiplier (leverage): 1.0313703932444618
ROE archetype: Low Return
Treasury beta 1y: 0.010669233501731708 (R-squared: 0.0015701038942369568)
Insider 90-day net shares: 5000000 (net value USD: 1000000.00)
ROIC (%): -3.2201431287549447 (pretax: -4.076130542727778)
Incremental ROIC 3y (%): 14.369890125063693 (pretax: 18.189734335523656)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 25.7285595337219, ROIC 11.906744379683596, revenue growth 1y , 6m momentum 42.88093255620316
Sector percentiles: P/E , 6m momentum 54.941699056079955
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.10896573425093345
Base cash flow: -2604387.6811594204
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for OMX.AX (Basic Materials — Other Precious Metals & Mining, Australia)
Report date: 2025-06-30 (annual)
Stock price: 0.04861111111111112
Market cap: 13910015 (USD: 9091513.071895424)
Current ratio: 1.91
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 40.97222222222225, 3m 13.425925925925943, 6m -11.284722222222214, 12m 4.861111111111126, composite -7.824853281031435 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 0, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.48 (Likely Safe)
ROE archetype: Standard Business
Treasury beta 1y: 0.0011946032120598118 (R-squared: 2.0626672158171897e-05)
Insider 90-day net shares: 500000 (net value USD: 26493.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y , 6m momentum 20.916905444126073
Sector percentiles: P/E , 6m momentum 36.00777345918934
Industry median P/E: 8.740359897172237; industry median ROIC: -12.638421644657798
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.0931
Base cash flow: 0
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for ONAU.V (Basic Materials — Gold, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.3546099290780142
Market cap: 36981708 (USD: 26605545.323741008)
P/B ratio: 17.62870221692798
Debt to equity: 0
Current ratio: 4.6563870015829485
Return on net tangible assets (%): -48.4577507905701
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: 5.527850745324475 (Safe Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -10.081053698074978, 3m -47.19395621338266, 6m -56.30699088145897, 12m 33.963750985027616, composite -18.172720497445894 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: 0.05003403729794692
FCF conversion rate: 1.181504748284842
Beneish M-score: -2.6872529893939516 (Likely Safe)
ROE (%): -40.34970497939601
Asset turnover: 0
Equity multiplier (leverage): 1.4637361766433805
ROE archetype: Low Return
Treasury beta 1y: -0.008876213289879548 (R-squared: 0.0014676355774943372)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 61.048158640226625, ROIC , revenue growth 1y , 6m momentum 72.80453257790369
Sector percentiles: P/E , 6m momentum 76.01332593003886
Industry median P/E: 8.322060300477567; industry median ROIC: -7.9824265928961236
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.1019
Base cash flow: -5581566.423357664
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for ONC (Healthcare — Biotechnology, Switzerland)
Report date: 2026-03-31 (quarterly)
Stock price: 325.9
Market cap: 33812520960 (USD: 33812520960)
P/E ratio: 67.03611738148986
P/B ratio: 4.736147465237892
Debt to equity: 0.4313
Current ratio: 3.64
Interest coverage ratio: 7.598808039650926
Return on net tangible assets (%): 4.846213714636688
Buffett classification: The Great
Analyst consensus upside (%): 39.960265346667995
Rule of 40 score: -2.6706116497927423
Altman Z-score: 3.9439468490663097 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Magic formula: return on capital % 3.798783730086947, earnings yield % 0.9326581285875888, rank 1604
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.15612386494166336
Total shareholder yield (%): -0.15612386494166336 (Minimal or Negative)
Momentum (%): 1m 17.602482678983826, 3m 8.34441489361701, 6m -3.9549687610515196, 12m 9.930513391351278, composite -0.7113998510643732 (Moderate Downtrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 7, short score 3, recommendation: Neutral
Revenue growth 1y (%): 48.76712240708652
Net income growth 1y (%): 19592.338582677166
Revenue deceleration: no
Accrual ratio: 0.007931926324007958
FCF conversion rate: 0.706144961448295
Beneish M-score: -2.5254595170999714 (Likely Safe)
ROE (%): 4.955016662348376
Net margin (%): 12.007305033195333
Asset turnover: 0.22480190455499932
Equity multiplier (leverage): 1.8356910451016208
ROE archetype: Low Return
P/E z-score: 1.7948535006044781
FCF z-score: 1.7948535006044777
Treasury beta 1y: -0.0016119412188982754 (R-squared: 0.00031694272963167584)
Insider 90-day net shares: -690621 (net value USD: -214310194.00)
ROIC (%): 33.95193432287902 (pretax: 49.3251024811695)
Incremental ROIC 3y (%): 290.3128944407457 (pretax: 378.4622501316749)
Capital allocation category: High-Efficiency Compounder
Industry percentiles: P/E 12.454873646209386, P/B 44.675090252707584, ROIC 2.256317689530686, revenue growth 1y 8.844765342960288, 6m momentum 31.046931407942242
Sector percentiles: P/E 32.09169054441261, 6m momentum 33.98997134670487
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.07172170304738495
Base cash flow: 307316455.6962025
DCF price per share: base 238.55800228705516, conservative 148.8409863159294, aggressive 408.9202759323402
Financial scorecard for ONESOURCE.NS (Healthcare — Biotechnology, India)
Report date: 2026-03-31 (annual)
Stock price: 17.07163501238646
Market cap: 189652697088 (USD: 2009884454.0907164)
P/B ratio: 2.8843478145999697
Debt to equity: 0.2579
Current ratio: 0.9888839496549511
Interest coverage ratio: 0.20566354298809184
Return on net tangible assets (%): -69.37819209599841
Buffett classification: The Gruesome
Analyst consensus upside (%): 13002.77370528745
Rule of 40 score: -50.428296290439846
Altman Z-score: 4.964634024784941 (Safe Zone)
Piotroski F-score: 2 (Weak)
Magic formula: return on capital % 1.6421186476689185, earnings yield % 0.09874827430110461, rank 2664
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 3.892469340085886, 3m -11.932710024903276, 6m 9.123073284983532, 12m -25.56949764998788, composite -10.389257336405358 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 6, recommendation: Neutral
Revenue growth 1y (%): -10.80674577306141
Revenue CAGR 3y (%): 217.31249920938112
Revenue deceleration: yes
Revenue growth consistency score: 365.1874361657806
Accrual ratio: 0.05886088601818151
FCF conversion rate: 7.595165508177175
Beneish M-score: -2.0377854580707986 (Likely Safe)
ROE (%): -1.1982745081329471
Net margin (%): -5.191581257605921
Asset turnover: 0.17191011879901028
Equity multiplier (leverage): 1.3426265284089138
ROE archetype: Low Return
Treasury beta 1y: 0.0010204622704821187 (R-squared: 0.0001147046564351787)
Insider 90-day net shares: 12517346 (net value USD: 18310353.00)
ROIC (%): 0.27511945410465066 (pretax: 0.3482524735501907)
Incremental ROIC 3y (%): 4.049562367082936 (pretax: 5.126028312763211)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 32.31046931407942, ROIC 9.296028880866427, revenue growth 1y 20.397111913357403, 6m momentum 21.299638989169676
Sector percentiles: P/E , 6m momentum 20.522922636103154
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.1018683288002116
Base cash flow: -38552246.714709625
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for ONT (Industrials — Waste Management, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 19.66
Market cap: 710497216 (USD: 710497216)
P/E ratio: 145.93333333333334
P/B ratio: 1.7975547762394597
Debt to equity: 0.8828
Current ratio: 1.84
Interest coverage ratio: -1.2625320160995244
Buffett classification: The Gruesome
Analyst consensus upside (%): 23.343992690726356
Rule of 40 score: -28.46064129538722
Altman Z-score: 0.6956951568698868 (Distress Zone)
Piotroski F-score: 4 (Weak)
Magic formula: return on capital % 6.0004752851711025, earnings yield % 1.1604359964205517, rank 4698
Dividend yield (%): 0
Buyback yield (%): 1.4073243039983987
Debt paydown yield (%): -4.148643982863966
Total shareholder yield (%): -2.741319678865567 (Minimal or Negative)
Momentum (%): 1m 10.449438202247187, 3m -7.044917257683209, 6m -14.447345517841603, 12m -14.965397923875434, composite -14.834214466120727 (Strong Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 1, short score 9, recommendation: Short
Revenue growth 1y (%): -5.238593294870498
Revenue deceleration: no
Accrual ratio: 0.004783034842864244
FCF conversion rate: 1.3635933806146572
Beneish M-score: -2.612870018832258 (Likely Safe)
ROE (%): -2.8476347128691097
Net margin (%): -7.530352840646103
Asset turnover: 0.1746916917316421
Equity multiplier (leverage): 2.1646949395578874
ROE archetype: Low Return
FCF z-score: 3.9962907098447435
Treasury beta 1y: 0.009516548661251654 (R-squared: 0.004746459126331249)
Insider 90-day net shares: -17444 (net value USD: -774098.00)
ROIC (%): 1.0270920762623297 (pretax: 1.5801416557881995)
Incremental ROIC 3y (%): 8.804731969306724 (pretax: 11.744247688098056)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 51.81818181818182, P/B 40, ROIC 51.81818181818182, revenue growth 1y 38.18181818181819, 6m momentum 58.18181818181818
Sector percentiles: P/E 66.25704045058883, 6m momentum 62.72401433691756
Industry median P/E: 2.2585383767903044; industry median ROIC: 4.739965171623647
Sector median P/E: 0.48479532163742683; sector median ROIC: 7.0952301251284755
WACC: 0.10883034183426105
Base cash flow: 34467000
DCF price per share: base 18.885719512715937, conservative 6.5515784395518395, aggressive 39.518454187509555
Financial scorecard for OSCR (Healthcare — Healthcare Plans, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 28.19
Market cap: 8499087360 (USD: 8499087360)
P/E ratio: 1.1168229075883567
P/B ratio: 1.8295189700596504
Debt to equity: 0.2893
Current ratio: 1.09
Return on net tangible assets (%): 40.923558266133156
Buffett classification: The Gruesome
Analyst consensus upside (%): 110.9851787271142
Rule of 40 score: 121.48478543360235
Piotroski F-score: 7 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): -0.009189221935471434
Total shareholder yield (%): -0.009189221935471434 (Minimal or Negative)
Momentum (%): 1m -3.3264746227709154, 3m 67.69779892920883, 6m 79.78316326530613, 12m 98.5211267605634, composite 84.27769162352378 (Strong Uptrend)
Lynch category: Fast Grower (confidence: Medium)
Screener: long score 8, short score 0, recommendation: Long
Revenue growth 1y (%): 52.55393247398534
Net income growth 1y (%): 143.17007234013755
Revenue deceleration: no
Accrual ratio: -0.2468731302101555
FCF conversion rate: 3.8232327596939872
Beneish M-score: -1.7598529927015907 (Possible Manipulation)
ROE (%): 51.56895410235658
Net margin (%): 14.690951141699701
Asset turnover: 0.5952196011836525
Equity multiplier (leverage): 5.897408133521516
ROE archetype: Leverage-Driven Returns
FCF z-score: 3.7720776396827502
Treasury beta 1y: -1.9503151217832916e-05 (R-squared: 1.4156561568406556e-08)
Insider 90-day net shares: -2819966 (net value USD: -97463404.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 5.263157894736842, P/B 36.84210526315789, ROIC , revenue growth 1y 5.263157894736842, 6m momentum 0
Sector percentiles: P/E 12.822349570200572, 6m momentum 3.187679083094556
Industry median P/E: 18.91807118149876; industry median ROIC: 10.186006764918668
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.15
Base cash flow: -450383000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for OSG (Financial Services — Insurance - Specialty, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 5.59
Market cap: 251625984 (USD: 251625984)
P/B ratio: 0.20330690685090377
Debt to equity: 0.1137
Current ratio: 1
Buffett classification: The Gruesome
Analyst consensus upside (%): 190.32258064516128
Rule of 40 score: 47.73223403106114
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.19711795742048643
Total shareholder yield (%): 0.19711795742048643 (Low Return)
Momentum (%): 1m -13.601236476043276, 3m 21.78649237472767, 6m -8.360655737704915, 12m -35.150812064965194, composite -3.8387195742020044 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 2, short score 4, recommendation: Neutral
Revenue growth 1y (%): 65.99209637325514
Revenue deceleration: no
Accrual ratio: 0.0032140083730797402
FCF conversion rate: 3.5204331121201538
Beneish M-score: -2.1626004749685466 (Likely Safe)
ROE (%): -0.27064213462248354
Net margin (%): -2.7483920514543536
Asset turnover: 0.046397346483331006
Equity multiplier (leverage): 2.122382142345663
ROE archetype: Low Return
Treasury beta 1y: -0.0011845189802962223 (R-squared: 5.853894217527642e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 8.695652173913043, ROIC , revenue growth 1y 4.3478260869565215, 6m momentum 82.6086956521739
Sector percentiles: P/E , 6m momentum 52.327987584066214
Industry median P/E: 9.39977249365699; industry median ROIC: 
Sector median P/E: 9.286368843069873; sector median ROIC: 1.3915857507207385
WACC: 0.1007712594175118
Base cash flow: -217139000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for PAT.L (Basic Materials — Gold, United Kingdom)
Report date: 2025-09-30 (quarterly)
Stock price: 0.002533333333333333
Market cap: 49418960 (USD: 66782378.37837838)
P/B ratio: 0.1298534640564072
Debt to equity: 0
Current ratio: 1.65
Buffett classification: The Gruesome
Analyst consensus upside (%): 3715625
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 1.3333333333333253, 3m -6.266666666666677, 6m -6.266666666666677, 12m 33.904761904761884, composite 6.536507936507927 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 2, recommendation: Neutral
Revenue deceleration: no
Beneish M-score: -2.6004612034363586 (Likely Safe)
Equity multiplier (leverage): 1.7393070919262705
ROE archetype: Standard Business
Treasury beta 1y: 0.011700106952498249 (R-squared: 0.006676949245094908)
Insider 90-day net shares: 158337 (net value USD: 36415.00)
ROIC (%): -133.64751453370187 (pretax: -169.17406903000239)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B 3.1161473087818696, ROIC 52.266288951841354, revenue growth 1y , 6m momentum 16.572237960339944
Sector percentiles: P/E , 6m momentum 31.70460855080511
Industry median P/E: 8.322060300477567; industry median ROIC: -7.9824265928961236
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.0931
Base cash flow: -3090097.4025974027
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for PEAK.V (Basic Materials — Other Precious Metals & Mining, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.3333333333333333
Market cap: 76361000 (USD: 54935971.22302159)
P/B ratio: 1.9726257745275173
Debt to equity: 0
Current ratio: 10.95
Return on net tangible assets (%): -8.744287113124331
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: 101.8589045711346 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 15.447154471544708, 3m 20.175438596491226, 6m 6.976744186046507, 12m 126.66666666666664, composite 41.163403650517274 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.03352931142257026
FCF conversion rate: 0.5921947133890532
Beneish M-score: -2.555202356947692 (Likely Safe)
ROE (%): -8.358670443173068
Asset turnover: 0
Equity multiplier (leverage): 1.0166358481999929
ROE archetype: Low Return
Treasury beta 1y: -0.0005691248284048627 (R-squared: 7.2520520241089115e-06)
Insider 90-day net shares: 375000 (net value USD: 96375.00)
ROIC (%): -5.973777147556722 (pretax: -7.561743224755345)
Incremental ROIC 3y (%): -2.577462281203596 (pretax: -3.262610482536198)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 19.484240687679083, ROIC 17.765042979942695, revenue growth 1y , 6m momentum 8.595988538681947
Sector percentiles: P/E , 6m momentum 16.90727373681288
Industry median P/E: 8.740359897172237; industry median ROIC: -12.638421644657798
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.15
Base cash flow: -1498525.5474452553
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for PEC.AX (Basic Materials — Other Industrial Metals & Mining, Australia)
Report date: 2024-06-30 (annual)
Stock price: 0.006944444444444445
Market cap: 15115877 (USD: 10077251.333333334)
P/B ratio: 4.849818958082542
Debt to equity: 0
Current ratio: 9.84
Return on net tangible assets (%): -258.3477370321793
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0.8609490537664469
Total shareholder yield (%): 0.8609490537664469 (Low Return)
Momentum (%): 1m -49.65277777777778, 3m -2.77777777777778, 6m 1.3888888888888886, 12m -47.56944444444444, composite 0.9163473818646265 (Flat)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 9, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.8625028247283297
FCF conversion rate: 0.36958408167175694
Beneish M-score: -3.0278012771061515 (Likely Safe)
ROE (%): -153.12021085621058
Equity multiplier (leverage): 1.119177996569889
ROE archetype: Low Return
Treasury beta 1y: 0.003400169997878262 (R-squared: 6.827058130692132e-05)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -340.5994271878433 (pretax: -431.1385154276497)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 43.54704412989175, ROIC 56.203164029975014, revenue growth 1y , 6m momentum 14.904246461282264
Sector percentiles: P/E , 6m momentum 20.960577456968352
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.10685
Base cash flow: -3834362.666666667
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for PGC.V (Basic Materials — Gold, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.02127659574468085
Market cap: 6919971 (USD: 4978396.402877699)
P/E ratio: 2.158273381294964
P/B ratio: 3.45547635835235
Debt to equity: 1.1359000000000001
Current ratio: 0.01
Interest coverage ratio: -1.3149142270894472
Return on net tangible assets (%): 64.17366353050011
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: -2.6642726376147223 (Distress Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.3306941836293672
Total shareholder yield (%): 0.3306941836293672 (Low Return)
Momentum (%): 1m 0.7092198581560277, 3m -2.836879432624105, 6m -2.1276595744680846, 12m -3.546099290780135, composite -3.0632970399227464 (Moderate Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 7, recommendation: Neutral
Revenue deceleration: no
Accrual ratio: 0.2847812832225415
FCF conversion rate: -0.02321234678608664
Beneish M-score: -2.509512852461353 (Likely Safe)
ROE (%): 95.42624575623883
Asset turnover: 0
Equity multiplier (leverage): 3.4286422113255757
ROE archetype: Leverage-Driven Returns
Treasury beta 1y: -0.000326698848873716 (R-squared: 4.638928530660514e-07)
Insider 90-day net shares: 900000 (net value USD: 19800.00)
ROIC (%): -10.68792588626011 (pretax: -13.529020109190013)
Incremental ROIC 3y (%): -12.27746061762195 (pretax: -15.541089389394871)
Capital allocation category: Value Destroyer
Industry percentiles: P/E 4.957507082152975, P/B 35.552407932011334, ROIC 34.13597733711048, revenue growth 1y , 6m momentum 14.164305949008499
Sector percentiles: P/E 19.48917268184342, 6m momentum 26.790671848972792
Industry median P/E: 8.322060300477567; industry median ROIC: -7.9824265928961236
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.06355562822690518
Base cash flow: -277983.9416058394
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for PGEN (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 5.49
Market cap: 1925159296 (USD: 1925159296)
P/B ratio: 68.18371596738325
Debt to equity: 4.8555
Current ratio: 4.82
Interest coverage ratio: -8.988116867262724
Return on net tangible assets (%): -331.369798971482
Buffett classification: The Gruesome
Analyst consensus upside (%): 221.7054263565891
Rule of 40 score: -1547.627714590088
Altman Z-score: -13.871267247613018 (Distress Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.0020777501416693158
Total shareholder yield (%): 0.0020777501416693158 (Low Return)
Momentum (%): 1m 1.6666666666666639, 3m 32.929782082324465, 6m 15.336134453781522, 12m 243.125, composite 95.25530551203532 (Strong Uptrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 0, short score 13, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): 131.8088105891126
Revenue deceleration: no
Accrual ratio: 0.24584880257843417
FCF conversion rate: 5.5599697313658725
Beneish M-score: 6.5748963083144005 (Strong Manipulation Signal)
ROE (%): -38.5408059106596
Net margin (%): -255.0701874888121
Asset turnover: 0.02113715032706404
Equity multiplier (leverage): 7.1484956010304765
ROE archetype: Low Return
Treasury beta 1y: -0.00803740665605048 (R-squared: 0.0011204359536849157)
Insider 90-day net shares: -853000 (net value USD: -4554838.00)
ROIC (%): -394.5743335051305 (pretax: -499.46118165206394)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 66.06498194945848, ROIC 36.462093862815884, revenue growth 1y 4.693140794223827, 6m momentum 17.509025270758123
Sector percentiles: P/E , 6m momentum 16.7621776504298
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.0980339757876268
Base cash flow: -249438000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for PL3.AX (Basic Materials — Other Industrial Metals & Mining, Australia)
Report date: 2025-12-31 (annual)
Stock price: 0.09027777777777779
Market cap: 30133192 (USD: 20223618.79194631)
P/B ratio: 0.9532545107325862
Debt to equity: 0
Current ratio: 8.8
Interest coverage ratio: -26.117936848363872
Return on net tangible assets (%): -11.811107939732416
Buffett classification: The Gruesome
Rule of 40 score: 0
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m 45.44753086419755, 3m -25.653594771241828, 6m 31.805555555555554, 12m 240.79861111111117, composite 46.82076853729998 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 2, short score 9, recommendation: Short
Revenue deceleration: no
Beneish M-score: -2.1395152130061454 (Likely Safe)
ROE (%): -14.06521540173706
Equity multiplier (leverage): 1.1256482485525543
ROE archetype: Low Return
Treasury beta 1y: 0.03641138335690681 (R-squared: 0.009168515228169579)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -8.718076104606375 (pretax: -11.035539372919462)
Capital allocation category: Standard Allocator
Industry percentiles: P/E , P/B 13.98834304746045, ROIC 22.231473771856784, revenue growth 1y , 6m momentum 6.9109075770191515
Sector percentiles: P/E , 6m momentum 7.162687395891172
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.05
Base cash flow: -1002306.7114093959
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for PNTG (Healthcare — Medical Care Facilities, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 41.16
Market cap: 1431032576 (USD: 1431032576)
P/E ratio: 35.44186046511628
P/B ratio: 2.7211535075339723
Debt to equity: 1.1662000000000001
Current ratio: 1.19
Interest coverage ratio: 5.639178617992178
Return on net tangible assets (%): -8.424593327819133
Buffett classification: The Good
Analyst consensus upside (%): 47.63779527559055
Rule of 40 score: -5.29177694337817
Altman Z-score: 2.0421701999988735 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Magic formula: return on capital % 4.787203134468361, earnings yield % 0.8993645118742024, rank 1444
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.026833770693980345
Total shareholder yield (%): 0.026833770693980345 (Low Return)
Momentum (%): 1m 19.028340080971656, 3m 37.15428190603131, 6m 34.81821159515229, 12m 78.18181818181816, composite 40.55648773271776 (Strong Uptrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 1, short score 5, recommendation: Neutral
Revenue growth 1y (%): 35.98993528464274
Net income growth 1y (%): 20.78150668857075
Revenue deceleration: no
Accrual ratio: 0.019710463598042877
FCF conversion rate: -0.8428057903429516
Beneish M-score: -2.390276557178111 (Likely Safe)
ROE (%): 2.695603440148333
Net margin (%): 3.6069721478532677
Asset turnover: 0.29653399062589136
Equity multiplier (leverage): 2.520221608824546
ROE archetype: Low Return
P/E z-score: 5.119945599534575
FCF z-score: 4.310900167377199
Treasury beta 1y: -0.0011766955805925198 (R-squared: 0.0001713004576730037)
Insider 90-day net shares: -10832 (net value USD: -417658.00)
ROIC (%): 4.64640148614521 (pretax: 6.279330050136416)
Incremental ROIC 3y (%): 5.997042537495304 (pretax: 8.656077547440068)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 58.57142857142858, P/B 48.095238095238095, ROIC 45.714285714285715, revenue growth 1y 6.666666666666667, 6m momentum 9.523809523809524
Sector percentiles: P/E 29.2621776504298, 6m momentum 9.13323782234957
Industry median P/E: 1.7425206697700268; industry median ROIC: 5.681103510179656
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.08249982094169818
Base cash flow: 30263000
DCF price per share: base 28.19137095475528, conservative 9.931144161321482, aggressive 61.72573926825951
Financial scorecard for PRCT (Healthcare — Medical Devices, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 16.69
Market cap: 949975552 (USD: 949975552)
P/B ratio: 4.0945510745627285
Debt to equity: 0.2243
Current ratio: 6.73
Interest coverage ratio: -39.86063569682152
Return on net tangible assets (%): -9.45661288602904
Buffett classification: The Gruesome
Analyst consensus upside (%): 17.153138744502193
Rule of 40 score: -56.257128659942296
Altman Z-score: 3.00152842871957 (Safe Zone)
Piotroski F-score: 3 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.05126447717256623
Total shareholder yield (%): 0.05126447717256623 (Low Return)
Momentum (%): 1m -19.952038369304557, 3m -31.486042692939236, 6m -42.705115001716436, 12m -71.53819918144612, composite -46.21174105965557 (Strong Downtrend)
Lynch category: Speculative (confidence: Low)
Screener: long score 4, short score 9, recommendation: Short
Revenue growth 1y (%): 20.198953182383384
Revenue deceleration: no
Accrual ratio: 0.018897786549269803
FCF conversion rate: 1.2972058916492826
Beneish M-score: -2.3056683934357127 (Likely Safe)
ROE (%): -8.867935369854681
Net margin (%): -38.05754703363326
Asset turnover: 0.167075485633723
Equity multiplier (leverage): 1.3946620847972846
ROE archetype: Low Return
Treasury beta 1y: 0.006901835099084509 (R-squared: 0.002243896292582402)
Insider 90-day net shares: -7373 (net value USD: -196145.00)
ROIC (%): -51.97884700665188 (pretax: -65.7960088691796)
Incremental ROIC 3y (%): -17.35344663881504 (pretax: -21.966388150398785)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 46.88427299703264, ROIC 49.85163204747774, revenue growth 1y 20.474777448071215, 6m momentum 62.61127596439169
Sector percentiles: P/E , 6m momentum 66.9054441260745
Industry median P/E: 21.626420273203117; industry median ROIC: -5.9391058628332924
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.09228720960695626
Base cash flow: -98538000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for PSN (Technology — Information Technology Services, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 58.73
Market cap: 6282848256 (USD: 6282848256)
P/E ratio: 25.91866028708134
P/B ratio: 2.104101720624496
Debt to equity: 0.6121
Current ratio: 1.75
Interest coverage ratio: 5.595574446805851
Return on net tangible assets (%): -47.42171643556078
Buffett classification: The Great
Analyst consensus upside (%): 27.709064057596468
Rule of 40 score: -9.025781180068465
Altman Z-score: 1.8419836933548877 (Grey Zone)
Piotroski F-score: 4 (Weak)
Magic formula: return on capital % 6.300304324447585, earnings yield % 1.1492323572561955, rank 1047
Dividend yield (%): 0
Buyback yield (%): 0.5568971042168044
Debt paydown yield (%): -4.687953424925118
Total shareholder yield (%): -4.131056320708313 (Minimal or Negative)
Momentum (%): 1m 20.249795249795234, 3m 9.878391019644516, 6m -19.24927815206931, 12m -22.26340172071476, composite -14.908319094880618 (Strong Downtrend)
Lynch category: Slow Grower (confidence: Medium)
Screener: long score 2, short score 9, recommendation: Neutral
Revenue growth 1y (%): -4.064952777992225
Net income growth 1y (%): -20.267279641018742
Revenue deceleration: no
Accrual ratio: 0.014230953546203491
FCF conversion rate: -0.28554998389842207
Beneish M-score: -2.3963365348537216 (Likely Safe)
ROE (%): 2.361934786462964
Net margin (%): 4.373125640434127
Asset turnover: 0.2531355137085306
Equity multiplier (leverage): 2.1336484704615084
ROE archetype: Low Return
P/E z-score: 4.7391388009986235
FCF z-score: 4.739138800998626
Treasury beta 1y: 0.0014912733230752293 (R-squared: 0.00020386491647252637)
Insider 90-day net shares: 42500 (net value USD: 2128718.00)
ROIC (%): 9.107441020066243 (pretax: 11.27906253893804)
Incremental ROIC 3y (%): 22.118496407013858 (pretax: 26.358748898470868)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E 62.63269639065817, P/B 42.675159235668794, ROIC 48.832271762208066, revenue growth 1y 39.91507430997877, 6m momentum 55.838641188959656
Sector percentiles: P/E 42.74274274274275, 6m momentum 53.92058725392058
Industry median P/E: 0.21619799348899724; industry median ROIC: 12.533738935242045
Sector median P/E: 1.5433673469387754; sector median ROIC: 6.677876317240262
WACC: 0.07399343610025622
Base cash flow: 424508000
DCF price per share: base 213.15230108532546, conservative 106.54985807902598, aggressive 409.2691636621951
Financial scorecard for PTCT (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 76.82
Market cap: 6372168192 (USD: 6372168192)
Debt to equity: -2.1892721580361845
Current ratio: 2.44
Interest coverage ratio: 0.9358759942892106
Buffett classification: The Great
Analyst consensus upside (%): 41.009834140613535
Rule of 40 score: 34.75400594854064
Altman Z-score: 0.5101414990170479 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Magic formula: return on capital % 3.1432427063425195, earnings yield % 0.6371265937745486, rank 1968
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 36.2824227223411
Total shareholder yield (%): 36.2824227223411 (High Return)
Momentum (%): 1m -8.991825613079024, 3m 12.589769895940186, 6m 2.086378737541519, 12m 65.84628670120897, composite 32.30281523246166 (Strong Uptrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 1, short score 7, recommendation: Neutral
Revenue growth 1y (%): 50.79460834927125
Net income growth 1y (%): -100.32415453250894
Revenue deceleration: no
Accrual ratio: 0.019967852956489493
FCF conversion rate: 21.500533997864007
Beneish M-score: -1.8737543477255385 (Likely Safe)
Net margin (%): -1.0306327989990864
Asset turnover: 0.0945066212472505
ROE archetype: Standard Business
P/E z-score: 1.48978107442993
FCF z-score: 1.4897810744299307
Treasury beta 1y: -0.0005866232446875211 (R-squared: 3.451534829077124e-05)
Insider 90-day net shares: -205006 (net value USD: -16830664.00)
ROIC (%): 150.85471041302407 (pretax: 153.9429886049103)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B , ROIC 0.5415162454873645, revenue growth 1y 8.574007220216606, 6m momentum 26.353790613718413
Sector percentiles: P/E , 6m momentum 26.002865329512893
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.0697559516879266
Base cash flow: 712669000
DCF price per share: base 527.0708531296688, conservative 275.1316759706743, aggressive 1009.1428846809887
Financial scorecard for RAMP.V (Basic Materials — Other Industrial Metals & Mining, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 0.19858156028368798
Market cap: 12592059 (USD: 9059035.251798563)
P/E ratio: 84.93848375569658
P/B ratio: 1.9087203433998001
Debt to equity: 0.0004
Current ratio: 7.17
Return on net tangible assets (%): -7.323090361987769
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: 6.417953902347373 (Safe Zone)
Piotroski F-score: 4 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.00040577073623105183
Total shareholder yield (%): 0.00040577073623105183 (Low Return)
Momentum (%): 1m 4.439190964013665, 3m -17.558564367074982, 6m -19.399249061326657, 12m -73.26030475387964, composite -37.11822991191689 (Strong Downtrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 8, recommendation: Short
Revenue deceleration: no
Accrual ratio: 0.10728227678913933
FCF conversion rate: -5.605230691760559
Beneish M-score: -2.908959055605771 (Likely Safe)
ROE (%): 1.8674862934255743
Asset turnover: 0
Equity multiplier (leverage): 1.1497870991329961
ROE archetype: Low Return
Treasury beta 1y: 0.0022414664704557548 (R-squared: 0.00011269596756126871)
Insider 90-day net shares: 78440 (net value USD: 21207.00)
ROIC (%): -59.25938538386758 (pretax: -75.01188023274376)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 15.570358034970857, P/B 26.56119900083264, ROIC 46.21149042464613, revenue growth 1y , 6m momentum 33.22231473771857
Sector percentiles: P/E 35.31371460299834, 6m momentum 43.47584675180455
Industry median P/E: 6.295008083084309; industry median ROIC: -14.271466134226909
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.05
Base cash flow: -3101607.299270073
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for RARE (Healthcare — Biotechnology, United States)
Report date: 2026-03-31 (quarterly)
Stock price: 26.9
Market cap: 2649360128 (USD: 2649360128)
Debt to equity: 0
Current ratio: 2.02
Interest coverage ratio: -8.047619047619047
Buffett classification: The Gruesome
Analyst consensus upside (%): 154.7494033412888
Rule of 40 score: -205.711479951858
Altman Z-score: -4.071131888518113 (Distress Zone)
Piotroski F-score: 1 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -7.591892820336657, 3m 11.618257261410776, 6m 11.1111111111111, 12m -1.465201465201473, composite 9.786468334186166 (Flat)
Lynch category: Turnaround (confidence: High)
Screener: long score 2, short score 9, recommendation: Short
Revenue growth 1y (%): -2.1582733812949617
Revenue deceleration: no
Accrual ratio: 0.01272984441301273
FCF conversion rate: 1.0972972972972972
Beneish M-score: -2.437673977641976 (Likely Safe)
Net margin (%): -136.02941176470588
Asset turnover: 0.09618104667609619
ROE archetype: Standard Business
Treasury beta 1y: -0.00018591140934952113 (R-squared: 1.4691360918716282e-06)
Insider 90-day net shares: -24017 (net value USD: -632482.00)
Capital allocation category: Capital-Light Grower
Industry percentiles: P/E , P/B , ROIC , revenue growth 1y 18.772563176895307, 6m momentum 20.216606498194945
Sector percentiles: P/E , 6m momentum 19.44842406876791
Industry median P/E: 6.198133227515053; industry median ROIC: -89.41034195162634
Sector median P/E: 4.824561403508772; sector median ROIC: 0.94429175936832
WACC: 0.08423365294930098
Base cash flow: -546000000
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for RAU.AX (Basic Materials — Gold, Canada)
Report date: 2026-03-31 (annual)
Stock price: 0.2152777777777778
Market cap: 32912566 (USD: 23678105.035971224)
P/B ratio: 4.022675267961658
Debt to equity: 0.011899999999999999
Current ratio: 2.6
Interest coverage ratio: -22386.785714285717
Return on net tangible assets (%): -56.59910927116321
Buffett classification: The Gruesome
Rule of 40 score: 0
Altman Z-score: 37.31376606179443 (Safe Zone)
Piotroski F-score: 2 (Weak)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.01709702588995926
Total shareholder yield (%): 0.01709702588995926 (Low Return)
Momentum (%): 1m 4.050925925925934, 3m -11.356209150326801, 6m 36.65458937198067, 12m 71.0891812865497, composite 29.908897460454494 (Strong Uptrend)
Lynch category: Cyclical (confidence: High)
Screener: long score 4, short score 8, recommendation: Short
Revenue deceleration: no
Accrual ratio: -0.01929305093842607
FCF conversion rate: 0.9632071471592673
Beneish M-score: -2.9249840729943832 (Likely Safe)
ROE (%): -55.14557938421941
Asset turnover: 0
Equity multiplier (leverage): 1.051654916361328
ROE archetype: Low Return
Treasury beta 1y: 0.007885768058206712 (R-squared: 0.001097678118855728)
Insider 90-day net shares: 0 (net value USD: 0.00)
ROIC (%): -58.011017467076556 (pretax: -73.43166767984374)
Incremental ROIC 3y (%): -20.367428910816354 (pretax: -25.78155558331184)
Capital allocation category: Value Destroyer
Industry percentiles: P/E , P/B 40.226628895184135, ROIC 47.73371104815864, revenue growth 1y , 6m momentum 3.2577903682719547
Sector percentiles: P/E , 6m momentum 6.107717934480844
Industry median P/E: 8.322060300477567; industry median ROIC: -7.9824265928961236
Sector median P/E: 1.5790983881237224; sector median ROIC: -1.992018401665734
WACC: 0.15
Base cash flow: -2764234.5323741008
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for RBA.NS (Consumer Cyclical — Restaurants, India)
Report date: 2026-03-31 (annual)
Stock price: 0.6725846407927333
Market cap: 46375604224 (USD: 491475246.1212378)
P/B ratio: 5.892111633444223
Debt to equity: 2.8566000000000003
Current ratio: 0.5
Interest coverage ratio: -0.32271964008490955
Return on net tangible assets (%): -27.17968406318736
Buffett classification: The Gruesome
Analyst consensus upside (%): 13903.471882640588
Rule of 40 score: -2.4447187397092995
Altman Z-score: 1.6710859143360202 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Total shareholder yield (%): 0 (Minimal or Negative)
Momentum (%): 1m -20.42684137892809, 3m -0.20977369540575194, 6m -3.838460788596723, 12m -30.877467628771065, composite -5.727196847979468 (Moderate Downtrend)
Lynch category: Turnaround (confidence: High)
Screener: long score 1, short score 11, recommendation: Strong Short (Melting Ice Cube)
Revenue growth 1y (%): 0.5608715487975147
Revenue deceleration: no
Beneish M-score: 0.5992277880016201 (Strong Manipulation Signal)
ROE (%): -6.246106167830155
Net margin (%): -6.0848454667123155
Asset turnover: 0.20898072087968225
Equity multiplier (leverage): 4.911946022954186
ROE archetype: Low Return
Treasury beta 1y: 0.00817845569233313 (R-squared: 8.360729056178595e-05)
Insider 90-day net shares: -300 (net value USD: -221.00)
ROIC (%): -1.979166171345369 (pretax: -2.505273634614391)
Incremental ROIC 3y (%): 22.25027136180356 (pretax: 28.16490045797918)
Capital allocation category: Turnaround Compounder
Industry percentiles: P/E , P/B 52.61194029850746, ROIC 70.8955223880597, revenue growth 1y 27.238805970149254, 6m momentum 42.16417910447761
Sector percentiles: P/E , 6m momentum 41.48122392211405
Industry median P/E: 0.6179805059642126; industry median ROIC: 6.022634691026258
Sector median P/E: 0.5734625271900335; sector median ROIC: 5.974200780604355
WACC: 0.05907633772677395
Base cash flow: -18006252.649427723
DCF price per share: base 0, conservative 0, aggressive 0
Financial scorecard for REAL.TO (Real Estate — Real Estate Services, Canada)
Report date: 2026-03-31 (quarterly)
Stock price: 3.5035460992907805
Market cap: 366977792 (USD: 264012800.00000003)
P/E ratio: 87.9958229426434
P/B ratio: 4.756691268156237
Debt to equity: 0.0141
Current ratio: 3.84
Interest coverage ratio: -3.3972602739726026
Return on net tangible assets (%): 4.344784002166749
Buffett classification: The Gruesome
Analyst consensus upside (%): 89.47894736842102
Rule of 40 score: -4.194027836864922
Altman Z-score: 10.425168185427488 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Dividend yield (%): 0
Buyback yield (%): 0
Debt paydown yield (%): 0.059722383203962004
Total shareholder yield (%): 0.059722383203962004 (Low Return)
Momentum (%): 1m -8.37872079202747, 3m -21.82641439693208, 6m -28.265673337963253, 12m -11.269595995615235, composite -17.74911068331588 (Moderate Downtrend)
Lynch category: Fast Grower (confidence: Medium)
Screener: long score 4, short score 7, recommendation: Neutral
Revenue growth 1y (%): 30.22207281064384
Revenue deceleration: no
Accrual ratio: 0.026572221415194934
FCF conversion rate: -1.3773898586866167
Beneish M-score: -2.0648924999843024 (Likely Safe)
ROE (%): 1.3384616490346808
Net margin (%): 2.5464628931882642
Asset turnover: 0.43892478464917456
Equity multiplier (leverage): 1.1975081424078493
ROE archetype: Low Return
Treasury beta 1y: 0.003459383795746628 (R-squared: 0.0010762438244468142)
Insider 90-day net shares: 25000 (net value USD: 106125.00)
ROIC (%): -11.95137868523996 (pretax: -15.128327449670836)
Capital allocation category: Standard Allocator
Industry percentiles: P/E 60.328638497652584, P/B 74.4131455399061, ROIC 80.51643192488262, revenue growth 1y 5.868544600938967, 6m momentum 76.52582159624414
Sector percentiles: P/E 51.39751552795031, 6m momentum 69.48757763975155
Industry median P/E: 0.9094611103569973; industry median ROIC: 3.7422962097312933
Sector median P/E: 4.332660990050401; sector median ROIC: 3.0025005588392872
WACC: 0.11680809148899055
Base cash flow: -14266187.050359713
DCF price per share: base 0, conservative 0, aggressive 0